Shoae-Hagh P, Razavi B, Sadeghnia H, Mehri S, Karimi G, Hosseinzadeh H
Mol Neurobiol. 2024; 62(4):5156-5182.
PMID: 39520654
DOI: 10.1007/s12035-024-04566-x.
Thaakur S, Himabindhu G
J Neural Transm (Vienna). 2009; 116(7):807-14.
PMID: 19444377
DOI: 10.1007/s00702-009-0232-y.
Lee L, Ong W, Farooqui A, Burgunder J
Psychopharmacology (Berl). 2007; 195(3):387-95.
PMID: 17768607
DOI: 10.1007/s00213-007-0912-y.
Del Bel E, Guimaraes F, Bermudez-Echeverry M, Gomes M, Schiaveto-de-souza A, Padovan-Neto F
Cell Mol Neurobiol. 2005; 25(2):371-92.
PMID: 16047547
PMC: 11529539.
DOI: 10.1007/s10571-005-3065-8.
Gao X, Hashimoto T, Cooper T, Tamminga C
J Neural Transm (Vienna). 1997; 104(1):97-104.
PMID: 9085197
DOI: 10.1007/BF01271298.
Effects of ceruletide on perioral movements and the dopamine receptor-adenylate cyclase system in rats chronically treated with fluphenazine.
Ashizawa T, Saito T, Takahata N
Psychopharmacology (Berl). 1996; 125(3):185-94.
PMID: 8815952
DOI: 10.1007/BF02247327.
Drug-induced oral dyskinesias in rats after traditional and new neuroleptics.
Kakigi T, Gao X, Tamminga C
J Neural Transm Gen Sect. 1995; 101(1-3):41-9.
PMID: 8695056
DOI: 10.1007/BF01271544.
Effect of chronic trifluoperazine administration and subsequent withdrawal on the production and persistence of perioral behaviours in two rat strains.
Collins P, Broekkamp C, Jenner P, Marsden C
Psychopharmacology (Berl). 1993; 112(4):437-44.
PMID: 7871054
DOI: 10.1007/BF02244891.
Electromyographical differentiation of the components of perioral movements induced by SKF 38393 and physostigmine in the rat.
Collins P, Broekkamp C, Jenner P, Marsden C
Psychopharmacology (Berl). 1993; 112(4):428-36.
PMID: 7871053
DOI: 10.1007/BF02244890.
Vacuous jaw movements induced by sub-chronic administration of haloperidol: interactions with scopolamine.
Steinpreis R, Baskin P, Salamone J
Psychopharmacology (Berl). 1993; 111(1):99-105.
PMID: 7870941
DOI: 10.1007/BF02257414.
The relationship between motor effects in rats following acute and chronic haloperidol treatment.
Jorgensen H, Andreassen O, Hole K
Psychopharmacology (Berl). 1994; 116(1):89-92.
PMID: 7862936
DOI: 10.1007/BF02244876.
Tiagabine inhibits haloperidol-induced oral dyskinesias in rats.
Gao X, Kakigi T, Friedman M, Tamminga C
J Neural Transm Gen Sect. 1994; 95(1):63-9.
PMID: 7857587
DOI: 10.1007/BF01283031.
Enhanced oral activity responses to intrastriatal SKF 38393 and m-CPP are attenuated by intrastriatal mianserin in neonatal 6-OHDA-lesioned rats.
Plech A, Brus R, Kalbfleisch J, Kostrzewa R
Psychopharmacology (Berl). 1995; 119(4):466-73.
PMID: 7480527
DOI: 10.1007/BF02245863.
Effect of daily dose of chronic haloperidol and chronic apomorphine on behavioral hypersensitivity in the rat.
Kinon B, Merson D, Kane J
Psychopharmacology (Berl). 1984; 84(3):347-51.
PMID: 6440181
DOI: 10.1007/BF00555211.
Characteristics of oral movements in rats during and after chronic haloperidol and fluphenazine administration.
See R, Levin E, Ellison G
Psychopharmacology (Berl). 1988; 94(3):421-7.
PMID: 3128820
DOI: 10.1007/BF00174701.
The pharmacological characterisation of pilocarpine-induced purposeless chewing behaviour in the rat.
Stewart B, Jenner P, Marsden C
Psychopharmacology (Berl). 1988; 96(1):55-62.
PMID: 2906443
DOI: 10.1007/BF02431533.
Pharmacological characterisation of spontaneous or drug-associated purposeless chewing movements in rats.
Rupniak N, Jenner P, Marsden C
Psychopharmacology (Berl). 1985; 85(1):71-9.
PMID: 2858901
DOI: 10.1007/BF00427326.
Chronic neuroleptic-induced mouth movements in the rat: suppression by CCK and selective dopamine D1 and D2 receptor antagonists.
Stoessl A, Dourish C, Iversen S
Psychopharmacology (Berl). 1989; 98(3):372-9.
PMID: 2568657
DOI: 10.1007/BF00451690.
Lateral striatal cholinergic mechanisms involved in oral motor activities in the rat.
Salamone J, Johnson C, McCullough L, Steinpreis R
Psychopharmacology (Berl). 1990; 102(4):529-34.
PMID: 2096410
DOI: 10.1007/BF02247136.
Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: a study in three rat strains.
Tamminga C, Dale J, Goodman L, Kaneda H, Kaneda N
Psychopharmacology (Berl). 1990; 102(4):474-8.
PMID: 1982902
DOI: 10.1007/BF02247127.
